Local injections of serotonin type-3 receptor antagonists as a therapeutic option in rheumatology

Future Medicinal Chemistry

Volumn 4, Issue 6, 2012, Pages 705-707

  Seidel, Matthias F ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

analgesic effect; antagonist; anti inflammatory; osteoarthritis; serotonin type 3 receptor

Indexed keywords

ANTIRHEUMATIC AGENT; CORTICOSTEROID; GRANISETRON; ONDANSETRON; SEROTONIN 2A ANTAGONIST; SEROTONIN 3 ANTAGONIST; TROPISETRON;

AUTONOMIC DYSFUNCTION; CONSTIPATION; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; FEASIBILITY STUDY; FIBROMYALGIA; HUMAN; IMMUNE SYSTEM; INFLAMMATION; NAUSEA AND VOMITING; OSTEOARTHRITIS; PAIN; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SYSTEMIC SCLEROSIS;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS; HUMANS; INJECTIONS; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS;

EID: 84860246844     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.12.15     Document Type: Review

References (19)

1. Seidel M, Tsalik J, Vetter H, Müller W. Substance P in rheumatic diseases. Curr. Rheum. Rev. 3, 17-30 (2007).
2. Seidel M, Herguijuela M, Forkert R, Otten U. Nerve growth factor in rheumatic diseases. Sem. Arthr. Rheum. 40(2), 109-126 (2010).
3. Cloëz-Tayarani I. Serotonin as a modulator of immune function: An overview. Curr. Immunol. Rev. 2, 27-35 (2006).
4. Kushnir-Sukhov NM, Brown JM, Wu Y et al. Human mast cells are capable of serotonin synthesis and release. J. Allergy Clin. Immunol. 119(2), 498-499 (2007).
5. Tominaga K, Alstergren P, Kurita H, Kopp S. Serotonin in an antigen-induced arthritis of the rabbit temporomandibular joint. Arch. Oral. Biol. 44, 595-601 (1999).
6. Harbuz MS, Perveen-Gill Z, Lalies MD et al. The role of endogenous serotonin in adjuvant-induced arthritis in the rat. Br. J. Rheumatol. 35(2), 112-116 (1996).
7. Nascimento EB Jr, Seniuk JG, Godin AM et al. Peripheral 5-HT1B and 5-HT2A receptors mediate the nociceptive response induced by 5-hydroxytryptamine in mice. Pharmacol. Biochem. Behav. 99(4), 598-603 (2011).
8. Färber L, Haus U, Späth M, Drechsler S. Physiology and pathophysiology of the 5-HT3 receptor. Scand. J. Rheumatol. Suppl. 119, 2-8 (2004).
9. Seidel MF, Fiebich BL, Ulrich-Merzenich G et al. Serotonin mediates PGE(2) overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells. Rheumat. Int. 28(10), 1017-1022 (2008).
10. Fiebich BL, Akundi RS, Seidel M et al. Expression of 5-HT3A receptors in cells of the immune system. Scand. J. Rheumatol. Suppl. 119, 9-11 (2004).
11. Stratz T, Färber L, Varga B et al. Fibromyalgia treatment with intravenous tropisetron administration. Drugs Exp. Clin. Res. 27(3), 113-8 (2001).
12. Seidel MF, Weinreich GF, Stratz T, Müller W. 5-HT3 receptor antagonists regulate autonomic cardiac dysfunction in primary fibromyalgia syndrome. Rheumatol. Int. 27(11), 1025-1030 (2007).
13. Maleki-Dizaji N, Eteraf-Oskouei T, Fakhrjou A et al. The effects of 5HT3. receptor antagonist granisetron on inflammatory parameters and angiogenesis in the air-pouch model of inflammation. Int. Immunopharmacol. 10(9), 1010-1016 (2010).
14. Hrycaj P. Serotonin type 3 receptor antagonist tropisetron in the treatment of chronic inflammatory rheumatic conditions - preliminary clinical experience. Scand. J. Rheumatol. Suppl. 119, 55-58 (2004).
15. Stratz T, Stauber A, Müller W. Local treatment of periarthropathies with the 5-HT3-receptor-Antagonist tropisetron. Z. Orthop. 140(4), 394-398 (2002).
16. Stratz T, Müller W. Local treatment of rheumatic diseases with the 5-HT3 receptor antagonist tropisetron. Schmerz 17(3), 13-18 (2003).
17. Samborski W, Stratz T, Mackiewicz S, Müller W. Intra-Articular treatment of arthritides and activated osteoarthritis with the 5-HT3 receptor antagonist tropisetron. A double-blind study compared with methylprednisolone. Scand. J. Rheumatol. Suppl. 119, 51-54 (2004).
18. Voog O, Alstergren P, Leibur E et al. Immediate effects of the serotonin antagonist granisetron on temporomandibular joint pain in patients with systemic inflammatory disorders. Life Sci. 68(5), 591-602 (2000).
19. Voog U, Alstergren P, Leibur E et al. Influence of serotonin on the analgesic effect of granisetron on temporomandibular joint arthritis. Mediators Inflamm. 13(5-6), 373-376 (2004).